280 related articles for article (PubMed ID: 17710673)
21. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
[TBL] [Abstract][Full Text] [Related]
22. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J
J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667
[TBL] [Abstract][Full Text] [Related]
23. [Prevalence of hemochromatosis-associated mutations in the hemochromatosis gene in the Danish population].
Larsen LE; Ellervik C; Appleyard M; Nordestgaard BG; Birgens H; Tybjaerg-Hansen A
Ugeskr Laeger; 2002 Sep; 164(39):4545-7. PubMed ID: 12380399
[TBL] [Abstract][Full Text] [Related]
24. A primer for predicting risk of disease in HFE-linked hemochromatosis.
Adams PC; Walker AP; Acton RT
Genet Test; 2001; 5(4):311-6. PubMed ID: 11960576
[TBL] [Abstract][Full Text] [Related]
25. Clinical Penetrance of Hereditary Hemochromatosis-Related End-Organ Damage of C282Y Homozygosity, A Newfoundland Experience.
Lim DR; Vidyasankar G; Phua C; Borgaonkar M
Clin Transl Gastroenterol; 2020 Nov; 11(11):e00258. PubMed ID: 33259166
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma and the penetrance of HFE C282Y mutations: a cross sectional study.
Willis G; Bardsley V; Fellows IW; Lonsdale R; Wimperis JZ; Jennings BA
BMC Gastroenterol; 2005 Jun; 5():17. PubMed ID: 15929796
[TBL] [Abstract][Full Text] [Related]
27. Hereditary hemochromatosis: missed diagnosis or misdiagnosis?
Cherfane CE; Hollenbeck RD; Go J; Brown KE
Am J Med; 2013 Nov; 126(11):1010-5. PubMed ID: 24054178
[TBL] [Abstract][Full Text] [Related]
28. Hereditary hemochromatosis.
Fix OK; Kowdley KV
Minerva Med; 2008 Dec; 99(6):605-17. PubMed ID: 19034258
[TBL] [Abstract][Full Text] [Related]
29. Penetrance, cancer incidence and survival in HFE haemochromatosis-A population-based cohort study.
Schaefer B; Pammer LM; Pfeifer B; Neururer S; Troppmair MR; Panzer M; Wagner S; Pertler E; Gieger C; Kronenberg F; Lamina C; Tilg H; Zoller H
Liver Int; 2024 Mar; 44(3):838-847. PubMed ID: 38263707
[TBL] [Abstract][Full Text] [Related]
30. Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study.
Barton JC; Leiendecker-Foster C; Reboussin DM; Adams PC; Acton RT; Eckfeldt JH;
Thyroid; 2008 Aug; 18(8):831-8. PubMed ID: 18651828
[TBL] [Abstract][Full Text] [Related]
31. Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people.
Deugnier Y; Jouanolle AM; Chaperon J; Moirand R; Pithois C; Meyer JF; Pouchard M; Lafraise B; Brigand A; Caserio-Schoenemann C; Mosser J; Adams P; Le Gall JY; David V
Br J Haematol; 2002 Sep; 118(4):1170-8. PubMed ID: 12199803
[TBL] [Abstract][Full Text] [Related]
32. Mutations of the HFE gene in patients with hepatocellular carcinoma.
Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P
Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066
[TBL] [Abstract][Full Text] [Related]
33. Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance.
Milet J; Dehais V; Bourgain C; Jouanolle AM; Mosser A; Perrin M; Morcet J; Brissot P; David V; Deugnier Y; Mosser J
Am J Hum Genet; 2007 Oct; 81(4):799-807. PubMed ID: 17847004
[TBL] [Abstract][Full Text] [Related]
34. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
[TBL] [Abstract][Full Text] [Related]
35. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
Phatak PD; Barton JC
Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
[TBL] [Abstract][Full Text] [Related]
36. [Hereditary hemochromatosis].
Niederau C
Med Klin (Munich); 2009 Dec; 104(12):931-46. PubMed ID: 20039160
[TBL] [Abstract][Full Text] [Related]
37. Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy.
Atkins JL; Pilling LC; Masoli JAH; Kuo CL; Shearman JD; Adams PC; Melzer D
JAMA; 2020 Nov; 324(20):2048-2057. PubMed ID: 33231665
[TBL] [Abstract][Full Text] [Related]
38. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
39. Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.
Grosse SD; Gurrin LC; Bertalli NA; Allen KJ
Genet Med; 2018 Apr; 20(4):383-389. PubMed ID: 28771247
[TBL] [Abstract][Full Text] [Related]
40. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
